1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
(
- Contribution to journal › Article
- 2020
-
Mark
Levels of Retinal Amyloid-β Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-β in Neuropathologically Evaluated Individuals
(
- Contribution to journal › Article
- 2019
-
Mark
Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer’s disease
(
- Contribution to journal › Article
- 2018
-
Mark
Levels of retinal IAPP are altered in Alzheimer's disease patients and correlate with vascular changes and hippocampal IAPP levels
(
- Contribution to journal › Article
- 2017
-
Mark
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
(
- Contribution to journal › Article
- 2015
-
Mark
The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.
(
- Contribution to journal › Article
- 2014
-
Mark
Involvement of Matrix Metalloproteinase-9 in Amyloid-β 1-42-Induced Shedding of the Pericyte Proteoglycan NG2.
(
- Contribution to journal › Article
-
Mark
Increased Levels of Hyaluronic Acid in Cerebrospinal Fluid in Patients with Vascular Dementia.
(
- Contribution to journal › Article
-
Mark
Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies.
2014) In Journal of Alzheimer's Disease(
- Contribution to journal › Article